Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Nov. 5, 2018. Iya Khalil.

Executive Summary

GNS Healthcare and its REFS (Reverse Engineering, Forward Simulation) AI platform is at the forefront of bringing targeted artificial intelligence solutions to biopharmaceutical companies, health plans and research organizations by helping to support better decision-making, better outcomes and cost savings. See what GNS cofounder Iya Khalil said about it here.

"Our goal is to not just predict disease. Our goal is to understand why you're getting a disease, so we know how to change it and to make recommendations as to what the best treatment is, or what the best biological new pathway to go after is." –Iya Khalil, cofounder, GNS Healthcare

Click here for a free trial of Medtech Insight

 
Advertisement

Related Content

Start-Up Spotlight: GNS Healthcare Deploys Causal Algorithms To Drive Health Outcomes, Save Costs

Topics

Advertisement
UsernamePublicRestriction

Register

MT123502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel